HER2 regulates HIF-2a and drives an increased hypoxic response in breast cancer. (2019)

First Author: Jarman EJ
Attributed to:  Implantable Microsystems for Personalised Anti-Cancer Therapy funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13058-019-1097-0

PubMed Identifier: 30670058

Publication URI: http://europepmc.org/abstract/MED/30670058

Type: Journal Article/Review

Volume: 21

Parent Publication: Breast cancer research : BCR

Issue: 1

ISSN: 1465-5411